Skip to main content
SpringerLink
Log in
Book cover

Asymptomatic Atherosclerosis pp 537–547Cite as

Cost Effectiveness of Screening Atherosclerosis

  • Chapter
  • First Online:

  • 1272 Accesses

Part of the book series: Contemporary Cardiology ((CONCARD))

Abstract

There remains a significant detection gap for cardiovascular disease that could be reduced provided that screening programs are employed, directed toward at-risk patient populations. However, given the current state of the healthcare system and the spiraling healthcare costs, expansion of current coverage decisions to include screening beyond cancer is incomprehensible. Data are unfolding that current tests are highly accurate at detecting risk and provide significant improvements in our global risk scores, such as the Framingham risk score. This chapter reviews the methods applied toward evaluating the economics of screening including cost-effectiveness principles. In addition to the presentation of screening cost models, this chapter introduces the concept of an early intervention model as a means to avert the enormous burden of symptomatic care in this country. Ongoing dialog about the importance of cost considerations and focused evaluations to consider the benefits and the risks of cardiovascular screening are important steps toward devising a platform for reducing the burden of atherosclerosis in this country.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. http://www.commonwealthfund.org/publications/publications_show.htm?doc_id=482678. Access date: April 11, 2008.

  2. http://www.meps.ahrq.gov/mepsweb/. Access date: March 29, 2008.

  3. http://www.cdc.gov/nchs/data/nvsr/nvsr56/nvsr56_10.pdf. Access date: April 11, 2008.

  4. Pasternak RC, Abrams J, Greenland P, Smaha LA, Wilson PW, Houston-Miller N. 34th Bethesda Conference: Task force #1-Identification of coronary heart disease risk: Is there a detection gap? J Am Coll Cardiol 2003;41(11):1863–74.

    Article  PubMed  Google Scholar 

  5. Murabito JM, Evans JC, Larson MG, Levy D. Prognosis after the onset of coronary heart disease. An investigation of differences in outcome between the sexes according to initial coronary disease presentation. Circulation 1993;88(6):2548–55.

    Article  PubMed  CAS  Google Scholar 

  6. Mark DB, Shaw LJ, Lauer MS, O’Malley P, Heidenreich P. 34th Bethesda Conference: Task force #5 – is atherosclerotic imaging cost effective? From the 34th Bethesda Conference on Atherosclerotic Imaging. J Am Coll Cardiol 2003;41(11):1906–17.

    Article  PubMed  Google Scholar 

  7. http://circ.ahajournals.org/cgi/reprint/CIRCULATIONAHA.107.187998. Access date: April 11, 2008.

  8. Shaw LJ, Bairey Merz CN, Pepine CJ, Reis SE, Bittner V, Kip K, Kelsey SF, Olson M, Johnson BD, Mankad S, Sharaf BL, Rogers WJ, Pohost GM, Sopko G, for the WISE Investigators. The economic burden of angina in women with suspected ischemic heart disease: Results from the National Institutes of Hevalth – National Heart, Lung, and Blood Institute – sponsored Women’s Ischemia Syndrome Evaluation. Circulation 2006;114:894–904.

    Article  PubMed  Google Scholar 

  9. Center for Medicaid and Medicare Services, Office of the Actuary, National Health Statistics Group. Access date: March 2, 2004.

    Google Scholar 

  10. Naghavi M, Falk E, Hecht H, Jamieson MJ, Kaul S, Berman D, Fayad Z, Budoff MJ, Rumberger J, Naqvu TZ, Shaw LJ, Faergeman O, Cohn J, Bahr R, Koenig W, Demirovic J, Arking D, Herrera VL, Badimon J, Goldstein JA, Rudy Y, Airaksinen J, Schwartz RS, Riley WA, Mendes RA, Douglas P, Shah PK, for the SHAPE Task Force. From vulnerable plaque to vulnerable patient – Part III: Executive summary of the Screening for Heart Attack and Prevention and Education (SHAPE) Task Force Report. Am J Cardiol 2006;98(2 Suppl 1):2–15.

    Article  Google Scholar 

  11. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003;289(1):76–9.

    Article  PubMed  Google Scholar 

  12. MEDPAC Analysis of Medicare Claims Data, March 17, 2005, Executive Director, Medicare Payment Advisory Commission, Mark Miller.htm.

    Google Scholar 

  13. Lucas FL, DeLorenzo MA, Siewers AE, Wennberg DE. Temporal trends in the utilization of diagnostic testing and treatments for cardiovascular disease in the United States, 1993–2001. Circulation 2006;113(3):374–9.

    Article  PubMed  CAS  Google Scholar 

  14. Personal communications, AMA/Specialty Society Relative Value Scale Update Committee (RUC).

    Google Scholar 

  15. http://www.rwjf.org/files/research/022008ib118final.pdf. Access date: March 28, 2008.

  16. Greenland P, Bonow RO, Brundage BH, Budoff MJ, Eisenberg MJ, Grundy SM, Lauer MS, Post WS, Raggi P, Redberg RF, Rodgers GP, Shaw LJ, Taylor AJ, Weintraub WS, Harrington RA, Abrams J, Anderson JL, Bates ER, Eisenberg MJ, Grines CL, Hlatky MA, Lichtenberg RC, Lindner JR, Pohost GM, Schofield RS, Shubrooks SJ Jr, Stein JH, Tracy CM, Vogel RA, Wesley DJ; American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography); Society of Atherosclerosis Imaging and Prevention; Society of Cardiovascular Computed Tomography. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: A report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2007;49(3):378–402.

    Article  PubMed  Google Scholar 

  17. Nasir K, Michos ED, Blumenthal RS, Raggi P. Detection of high-risk young adults and women by coronary calcium and National Cholesterol Education Program Panel III guidelines. J Am Coll Cardiol 2005;46(10):1931–6.

    Article  PubMed  Google Scholar 

  18. Akosah KO, Schaper A, Cogbill C, Schoenfeld P. Preventing myocardial infarction in the young adult in the first place: How do the National Cholesterol Education Panel III guidelines perform? J Am Coll Cardiol 2003;41(9):1475-9.

    Article  PubMed  Google Scholar 

  19. Michos ED, Nasir K, Braunstein JB, Rumberger JA, Budoff MJ, Post WS, Blumenthal RS. Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women. Atherosclerosis 2006;184(1):201-6.

    Article  PubMed  CAS  Google Scholar 

  20. Nasir K, Budoff MJ, Wong ND, Scheuner M, Herrington D, Arnett DK, Szklo M, Greenland P, Blumenthal RS. Family history of premature coronary heart disease and coronary artery calcification: Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2007;116(6):619-26.

    Article  PubMed  Google Scholar 

  21. Shaw LJ, Raggi P, Berman DS. Cost effectiveness of screening for CVD with measures of coronary calcium. Prog Cardiov Dis 2003;46:171-84.

    Article  Google Scholar 

  22. http://www.acponline.org/journals/ecp/sepoct00/primer.htm. Access date: July 15, 2006.

  23. Fowler-Brown A, Pignone M, Pletcher M, Tice JA, Sutton SF, Lohr KN; U.S. Preventive Services Task Force. Exercise tolerance testing to screen for coronary heart disease: A systematic review for the technical support for the U.S. Preventive Services Task Force. Ann Intern Med 2004;140(7):W9-24.

    Article  PubMed  Google Scholar 

  24. O’Malley PG, Greenberg BA, Taylor AJ. Cost-effectiveness of using electron beam computed tomography to identify patients at risk for clinical coronary artery disease. Am Heart J 2004;148(1):106–13.

    Article  PubMed  Google Scholar 

  25. Taylor AJ, Bindeman J, Feurerstein I, Cao F, Brazaitis M, O’Malley PG. The independent prognostic value of coronary calcium over measured cardiovascular risk factors in an asymptomatic male screening population: 6-year outcomes in the prospective army coronary calcium project. J Am Coll Cardiol 2005;46(5):807-14.

    Article  PubMed  CAS  Google Scholar 

  26. Treesak C, Kasemsup V, Treat-Jacobson D, Nyman JA, Hirsch AT. Cost-effectiveness of exercise training to improve claudication symptoms in patients with peripheral arterial disease. Vasc Med 2004;9(4):279–85.

    Article  PubMed  Google Scholar 

  27. Derdeyn CP, Powers WJ. Cost-effectiveness of screening for asymptomatic carotid atherosclerotic disease. Stroke 1996;27:1944-50.

    Article  PubMed  CAS  Google Scholar 

  28. Blake GJ, Ridker PM, Kuntz KM. Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia. Am J Med 2003;114:485–494.

    Article  PubMed  Google Scholar 

  29. Heidenreich PA, Gubens MA, Fonarow GC, Konstam MA, Stevenson LW, Shekelle PG. Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced LVEF. J Am Coll Cardiol 2004;43(6):1019–26.

    Article  PubMed  CAS  Google Scholar 

  30. Hoerger TJ, Hicks KA, Sorensen SW, Herman WH, Ratner RE, Ackermann RT, Zhang P, Engelgau MM. Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults. Diabetes Care 2007;30:2874–79.

    Article  PubMed  Google Scholar 

  31. Shaw LJ, Berman DS, Blumenthal RS, Budoff MJ, Faber TL, Goraya T, Halliburton SS, Hecht H, Kiat H, Koenig W, Malik S, Merhige M, Nasir K, Min JK, O’Keefe J, Polk DM, Raggi P, Rosenblatt JA, Schwartz RG, Taylor AJ, Thomas GS, Wijns W. Clinical imaging for prevention: Directed strategies for improved detection of presymptomatic patients with undetected atherosclerosis-Part I: Clinical imaging for prevention. J Nucl Cardiol 2008;15(1):e6–19.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA

    Leslee J. Shaw

  2. Department of Radiology, Cardiac MRI-PET-CT Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA

    Ron Blankenstein

Authors
  1. Leslee J. Shaw
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ron Blankenstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Endothelix, Inc., El Rio 8275, Houston, 77054, USA

    Morteza Naghavi

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Shaw, L.J., Blankenstein, R. (2011). Cost Effectiveness of Screening Atherosclerosis. In: Naghavi, M. (eds) Asymptomatic Atherosclerosis. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-179-0_40

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-179-0_40

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60327-178-3

  • Online ISBN: 978-1-60327-179-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation